Antitumor Effect of IL-2 and CIK Cells on Malignant Melanoma in Mice

Lu Lan,Xie Jun,Che Biao,Xie Conghua,Shi Xingwei
DOI: https://doi.org/10.3760/cma.j.issn.1674-1927.2017.05.007
2017-01-01
Abstract:Objective To investigate the antitumor effect of IL-2 and CIK cells on cutaneous malignant melanoma in mice and its mechanism. Methods The mice model of B16 cutaneous malignant melanoma was established. All the mice were randomly divided into four groups:control group(n=9), injected with 0.2 ml normal saline per mice in peritumoral tissues;IL-2 group(n=9),injected with 0.2 ml IL-2(500 IU/ml)per mice in peritumoral tissues;CIK group(n=9),injected with 0.2 ml CIK cells(about 1×107CIK cells)per mice in peritumoral tissues;and IL-2+CIK group(n=9),injected with IL-2 and CIK cells in peritumoral tissues. Injection scheme:once a week for continuous 3 weeks,and to determine the tumor growth curve,calcμlate the cell apoptosis rate,and measure the spleen weight.Results In the study group,the tumor growth significantly slowed down or dissipated.The apoptosis rate significantly increased, the apoptosis rate of control group,IL-2 group,CIK group,and IL-2+CIK group:(3.80±2.70)%,(19.09± 3.71)%,(23.07 ± 4.15)%,(49.35 ± 4.91)%. The spleen weight increased,the spleen weight in the four groups:(57.18 ± 6.70)mg,(98.34 ± 10.71)mg,(109.47 ± 11.51)mg,(142.35 ± 12.10)mg). There were statistically significant differences compared with those in the control group.The anti-tumor effect and spleen enlargement were the most obvious in the IL-2+CIK group.Conclusion The therapy of IL-2 and CIK cells shows significant anti-tumor effect on B16 cutaneous malignant melanoma in mice,which is better than CIK cells or IL-2 monotherapy.Its mechanism may be associated with the synergy effect of IL-2 and CIK cells for enhancement of tumor immunity.
What problem does this paper attempt to address?